Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
42,431
Sort by:
Europe Coagulation Testing Analyzers and Reagents Market 2021: France, Germany, Italy, Spain, UK-Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 17,730.00
... provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market ... and consumable suppliers during the next five years. Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated ...
May 2017
500 pages
Latin America Clinical Chemistry Reagents and Analyzers Market 2021: A 7-Country Analysis-Supplier Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review
US$ 7,875.00
... creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices ... over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays. Individual Tests Analyzed in the Report Clinical Chemistry Albumin ...
May 2017
620 pages
Middle East Clinical Chemistry Reagents and Analyzers Market 2021: An 11-Country Analysis-Supplier Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review
US$ 10,350.00
... creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices ... over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays. Individual Tests Analyzed in the Report Clinical Chemistry Albumin ...
May 2017
700 pages
North America Clinical Chemistry Reagents and Analyzers Market 2021: USA, Canada, Mexico-Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 12,150.00
... identifies specific product and marketing opportunities for reagent and instrument suppliers. Rationale Clinical chemistry and immunodiagnostic markets are undergoing significant transformation ... for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays. Individual Tests Analyzed in the Report Clinical Chemistry Albumin, Alkaline ...
May 2017
635 pages
